# Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)

> **NCT00945789** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tanta University** · enrollment: 45 (actual)

## Conditions studied

- Hypoxic Ischemic Encephalopathy

## Interventions

- **DRUG:** Human recombinant erythropoietin
- **PROCEDURE:** EEG and Brain MRI
- **BIOLOGICAL:** Nitric oxide measurement in the blood

## Key facts

- **NCT ID:** NCT00945789
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-12
- **Final completion:** 2009-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2009-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00945789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00945789, "Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00945789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*